---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-258519"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:32:52.464206+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q1 FY2026 revenue +9% to $1.34B; non-GAAP EPS $2.55 (+16%); dividend $0.60

## Summary
- Revenue $1,335.6M (+9% YoY, +8% constant currency); diluted EPS $2.37, non-GAAP EPS $2.55 (+16%).
- Gross margin up 290 bps to 61.5%; non-GAAP gross margin 62.0% (up 280 bps).
- Operating cash flow $457M; income from operations +15% (+19% non-GAAP).
- Board declared quarterly dividend of $0.60 per share, payable Dec 18 to holders of record Nov 13.

## SEC filing metadata
- accession: 0001193125-25-258519
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/0001193125-25-258519-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/d92301d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-258519
- JSON: https://secwatch.observer/filing/0001193125-25-258519.json
- Plain text: https://secwatch.observer/filing/0001193125-25-258519.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.